US EditionUS FDA approves higher dose of Novo's Wegovy
Wegovy HD delivers an average 20.7% weight loss at 72 weeks, offering a new option for adults not meeting goals with the 2.4 mg dose, FDA says.
- The US FDA has approved a higher 7.2-milligram dose of Novo Nordisk's obesity drug Wegovy, with an expected launch in April to compete with Eli Lilly's obesity drug Zepbound.
- In clinical trials, the high-dose Wegovy enabled patients to lose an average of 20.7% of their body weight after 72 weeks, compared to about 15% weight loss with the standard 2.4-milligram dose.
- Wegovy HD is approved for use in adults with obesity who have tolerated the 2.4 mg dose for at least 4 weeks and are seeking greater weight reduction alongside diet and exercise.
- Experts view Wegovy HD as a new treatment option that could improve obesity management and patient outcomes.
49 Articles
49 Articles
abc10 News
Fast-track FDA approval brings stronger Wegovy to pharmacies by April
The Food and Drug Administration has approved a higher-dose version of the weight-loss drug Wegovy through a pilot program designed to accelerate drug approvals.The agency said Thursday that 7.2-milligram injectable doses of Wegovy are now approved for certain adult patients. Those eligible include people with obesity and overweight patients with at least one underlying health condition.The drug is available only after a patient has tolerated a …
FDA greenlights higher-dose GLP-1 obesity shots
The Food and Drug Administration approved a higher-dose version of a popular class of obesity drugs on Thursday, the latest expansion in a rapidly growing market for weight-loss treatments. The newly authorized dose of Novo Nordisk’s Wegovy increases the maximum weekly injection from 2.4 milligrams to 7.2 milligrams, offering patients a stronger option if they have not achieved the desired results with existing therapies. Federal regulators cle…
High-Dose Wegovy Wins FDA Approval
(MedPage Today) -- The FDA approved a higher dose of the GLP-1 receptor agonist semaglutide for weight loss, dubbed Wegovy HD, the agency announced on Thursday. The once-weekly injectable will come in a 7.2-mg dose -- three times the strength...
Coverage Details
Bias Distribution
- 69% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
